QuellTX
Cillian O'Ceallaigh started their work experience at the Apoptosis Research Centre in April 2019 as a Research Assistant, and their role ended in November 2019. In January 2020, they joined Autolus Ltd. as a Production Associate and remained in that role until December 2020. Since December 2020, Cillian has been working at Quell Therapeutics, initially as a Research Associate in Treg Production and then as a Research Associate in Product Discovery. In December 2022, they were promoted to the role of Senior Research Associate in Product Discovery at Quell Therapeutics, where they are currently employed.
Cillian O'Ceallaigh completed their education at the University of Galway from 2018 to 2019, where they obtained a Master of Science degree in Cellular Manufacturing & Therapy. Cillian'sfield of study during this period focused on Cellular Therapies. Prior to that, from 2014 to 2018, they attended Maynooth University and earned a Bachelor of Science degree in Biomedical Science. Cillian'sarea of concentration during this time was Immunology and Molecular Biology.
This person is not in the org chart
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.